drugset / Trial / NCT06941077
A Study to Evaluate the Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the Relative Bioavailability of New Formulations of INCB057643 Tablets Administered Orally in Healthy Participants.
Timeline
- Start
- 2025-05-12
- Primary completion
- 2025-06-03
- Completion
- 2025-06-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INCB057643 | Small molecule | — | Oral |
Indications
No indication recorded.